A new College of American Pathologists article explores how multiplex immunofluorescence can assess multiple biomarkers in a single tissue section while conserving samples for additional testing.
Pathologists are being asked to get more answers from less tissue, and multiplex immunofluorescence may help by evaluating multiple protein markers on the same tissue section while preserving the spatial relationships among cells.
The approach is the focus of a new article from the College of American Pathologists Personalized Health Care Committee. According to the committee, a single cancer biopsy may need to establish a diagnosis, identify treatment-related biomarkers, and support genomic testing, all while tissue is preserved for other essential testing.
“The future of pathology isn’t simply about doing more tests. It’s about extracting more meaningful information from every tissue sample,” says Jordan Seth Laser, MD, FCAP, an advisor to the committee, in a release.
Read the full article: CAP Examines How Labs Can Get More Diagnostic Information From Smaller Biopsies